Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

PharmaData

PharmaData are award-winning specialists in pharmaceutical data analytics driving strategy, engaging teams and measuring change across Australia and Europe. Our proprietary products help our clients identify and act on opportunities to; increase generic substitution, improve efficiency, engage sales forces, drive strategy, build ‘sticky’ business relationships, achieve greater depth in market, encourage customer loyalty and help deliver more patient centric care.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

- PMLiVE

Genetic Digital

We guide healthcare and life sciences organisations through digital transformation. Simplifying the complex world of tech and marketing, we create impactful assets and strategies to drive long-term growth and positive…

View Profile

Creative and design, Digital communications, IT solutions, Marketing consultancies, Medical communications

- PMLiVE

Nmblr

From day-one concept to launch and beyond, Nmblr is the strategy and collaboration platform that partners with biopharma teams.

View Profile

IT solutions

Company Details

PharmaData
The Limestore, Level 1 33 Longland Street, Newstead, Queensland, 4006, Australia
+617 3171 9900
Contact PharmaData
Website

 Latest Content from PMHub 

11 London are delighted to announce our collaboration with health psychologist, Prof. Anne Manyande

Press Releases | March 15, 2022 | 11 London

As an agency, we take a deeper and a more considered approach to health marketing and communications founded on expert collaborations. We are therefore, thrilled to be working with Professor...

Virtual Product Launch Planning & Preparation: A Customer Story

White Papers and Resources | March 14, 2022 | Impetus Digital

For this Pre-Product Launch Longitudinal Expert Engagement Plan™ (LEEP™), our client leveraged Impetus Digital’s cutting-edge virtual tools, comprehensive online platform, and White-Glove™ digital and strategic services to engage a group...

Extraordinary lives: advancing change in rare diseases (Part 1)

Videos and Podcasts | March 14, 2022 | Lucid Group Communications Limited

Extraordinary lives: advancing change in rare diseases (Part 1)

Press Releases | March 14, 2022 | Lucid Group Communications Limited

Rare Disease Day is all about raising awareness and generating change for the 300 million people worldwide living with a rare disease. The global rare disease community and its supporters come together on...

How do doctors spend their time online?

White Papers and Resources | March 14, 2022 | M3 (EU)

In our recent research piece, Doctor networks: The rules of engagement for pharma, some overarching principles for online engagement between the pharmaceutical industry and doctors were defined.

The Seven Year Switch

Press Releases | March 14, 2022 | 11 London

7 years ago this month, no-one had heard of Covid 19 – let alone PCR tests. The UK was in the EU, Donald Trump was only really known for being...

Increasing patient randomisation rate by 200% for a Top 5 global pharma

White Papers and Resources | March 10, 2022 | Innovative Trials

Phase IIa Moderate to Severe Hidradenitis Suppurativa Case Study

Creative Director, Europe appointment at Nucleus Global

Press Releases | March 10, 2022 | Nucleus Global

We hear from Trevor Telo, Nucleus Global’s new Creative Director, Europe, about his experience and ambitions for the role

Top 10 Tips to Increase Engagement During Virtual Events

Videos and Podcasts | March 10, 2022 | Impetus Digital

If you are a member of the Medical Affairs Professional Society (MAPS), you might have caught our popular webinar on how COVID-19 has impacted (and will continue to impact) live...

Consumer-driven Healthcare in the Digital Age

Videos and Podcasts | March 10, 2022 | Impetus Digital

Dr. Gil Blander, Co-founder & Chief Scientific Officer at InsideTracker, explores consumer-driven healthcare, the use of big data and AI for creating personalized health protocols, the trillion-dollar “longevity economy,” and...